Bio-Rad (BIO) Stock Price & AI Analysis

$230.19
-$0.32
(0.14%)
Life Sciences Tools & Services

NYSE USA

June 12, 2:02 PM EDT
  • Market Cap.
    6.27B
  • Volume
    486,153
  • Avg. Volume
    378.78K
  • Target Price
    $313.50
  • 52W Range
    211.43 - 387.99
  • RSI (14)
    48.88
  • Beta
    0.94
  • PEG Ratio
  • SMA 20
    0.0400%
  • SMA 50
    -2.65%
  • SMA 200
    -23.44%
  • Insider Owner
    32.15%
  • Insider Trans
    -0.03%
  • Institution Owner
    73.81%
  • Institution Trans
    4.43%
  • Short Interest
    1.22%
  • EPS next Y
    11.6

Bio-Rad Company Profile

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.
Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells, and supports test systems, informatics systems, and test kits. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Bio-Rad | Latest news

Nuvation Bio stock falls after FDA approves lung cancer drug By Investing.com

Nuvation Bio Inc (NYSE:NUVB) stock fell 13% after receiving FDA approval for its lung cancer drug...

Investingcom - 9 hours ago

JetBlue flight rolls off runway at Boston's Logan Airport upon arrival from...

A JetBlue flight landing at Logan Airport in Boston from Chicago rolled off the runway and on to the...

CBS News - 2 hours ago

Kennedy's new CDC panel includes members who have criticized vaccines and spread...

U.S. Health Secretary Robert F. Kennedy Jr. on Wednesday named eight new vaccine policy advisers to...

FOX23 News - 4 hours ago

10-year-old reported in critical condition after two-vehicle crash in Waterford...

Four people were injured – including a 10-year-old child– during a crash Wednesday in Oakland...

CBS News - 2 hours ago

All You Need to Know About Annovis Bio (ANVS) Rating Upgrade to Buy

Annovis Bio (ANVS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the...

Zacks - 1 day ago

Nuvation Bio’s (NUVB) Outperform Rating Reaffirmed at Wedbush

Wedbush reiterated their outperform rating on shares of Nuvation Bio (NYSE:NUVB – Free Report) in a research note issued to investors on Wednesday,Benzinga reports. Jones Trading began coverage ...

ETF DAILY NEWS - 15 hours ago

DHS official asks Kim Kardashian which murderers, rapists she would like to see...

NEWYou can now listen to Fox News articles! Assistant Department of Homeland Security Secretary...

Fox News - 2 hours ago

Cantor Fitzgerald Forecasts Gossamer Bio FY2026 Earnings

Gossamer Bio, Inc. (NASDAQ:GOSS – Free Report) – Research analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for shares of Gossamer Bio in a report released ...

ETF DAILY NEWS - 15 hours ago

EXCLUSIVE: Intelligent Bio Solutions Expands US Forensic Market Presence, Seeks...

Intelligent Bio Solutions Inc. (NASDAQ:INBS) announced an update on its growing footprint in the...

Benzinga - 1 day ago

De'Adre Aziza (Actor): Credits, Bio, News & More | Broadway World

Looking to find out more about De'Adre Aziza (Actor)? We have a full Biography, Photos, Theatre...

Broadway World - 3 hours ago